- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Metastatic Triple-Negative Breast Cancer ; volume:15 ; number:3 ; day:17 ; month:6 ; year:2023 ; pages:288-297 ; date:9.2023
Current breast cancer reports ; 15, Heft 3 (17.6.2023), 288-297, 9.2023
- Urheber
-
Zhang, Xiaojie
Yeung, Kay T.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12609-023-00493-3
- URN
-
urn:nbn:de:101:1-2023120808555802686875
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:30 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zhang, Xiaojie
- Yeung, Kay T.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Updated Austrian treatment algorithm for metastatic triple-negative breast cancer
Metastatic and triple-negative breast cancer: challenges and treatment options
Practical consensus recommendations on management of triple-negative metastatic breast cancer
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
SABCS 2020: update on triple-negative and metastatic HER2-positive breast cancer
PI3K inhibition circumvents resistance to SHP2 blockade in metastatic triple-negative breast cancer
The Gαh-PLCδ1 signaling axis drives metastatic progression in triple-negative breast cancer
MicroRNA signatures in triple-negative breast cancer
New Vaccine Therapy for Triple-Negative Breast Cancer
Immune-related biomarkers in triple-negative breast cancer
Advances in immunotherapy for triple-negative breast cancer
Updated Austrian treatment algorithm for metastatic triple-negative breast cancer
Metastatic and triple-negative breast cancer: challenges and treatment options
Practical consensus recommendations on management of triple-negative metastatic breast cancer
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
SABCS 2020: update on triple-negative and metastatic HER2-positive breast cancer
PI3K inhibition circumvents resistance to SHP2 blockade in metastatic triple-negative breast cancer
The Gαh-PLCδ1 signaling axis drives metastatic progression in triple-negative breast cancer
MicroRNA signatures in triple-negative breast cancer
New Vaccine Therapy for Triple-Negative Breast Cancer
Immune-related biomarkers in triple-negative breast cancer
Advances in immunotherapy for triple-negative breast cancer
Updated Austrian treatment algorithm for metastatic triple-negative breast cancer
Metastatic and triple-negative breast cancer: challenges and treatment options
Practical consensus recommendations on management of triple-negative metastatic breast cancer
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
SABCS 2020: update on triple-negative and metastatic HER2-positive breast cancer
PI3K inhibition circumvents resistance to SHP2 blockade in metastatic triple-negative breast cancer
The Gαh-PLCδ1 signaling axis drives metastatic progression in triple-negative breast cancer
MicroRNA signatures in triple-negative breast cancer
New Vaccine Therapy for Triple-Negative Breast Cancer
Immune-related biomarkers in triple-negative breast cancer